CQC: controlled drugs annual report 2025

The safer management of controlled drugs 2025 highlights the Care Quality Commission’s oversight activity under the Controlled Drugs (Supervision of Management and Use) Regulations 2013. Private prescribing of unlicensed schedule 2 cannabis products rose by 134%, from 356,335 items 1 April 2023-31 March 2024 to 833,525 items 1 April 2024-31 March 2025.